Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tamir Fishman is a prominent Israeli investment house that operates extensively within the life sciences and healthcare sectors through its dedicated venture capital arms. Established in 1997, the firm provides a comprehensive suite of financial services, including investment banking, private equity, and asset management. The Tamir Fishman Life Science Fund specifically targets innovative Israeli companies developing medical devices, biopharmaceuticals, and digital health solutions. The firm plays a pivotal role in the Israeli ecosystem by providing capital and strategic guidance to startups from early-stage R&D through to international commercialization. Their portfolio has historically spanned diverse therapeutic areas such as oncology, cardiology, and metabolic disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tamir Fishman.